Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 4.

Article

Witjes, JA, Babjuk, M, Bellmunt, J et al. (118 more authors) (2020) EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees. European Urology, 77 (2). pp. 223-250. ISSN 0302-2838

Mateo, J, Porta, N, Bianchini, D et al. (38 more authors) (2020) Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial. The Lancet Oncology, 21 (1). pp. 162-174. ISSN 1470-2045

Horwich, A, Babjuk, M, Bellmunt, J et al. (118 more authors) (2019) EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees. Annals of Oncology, 30 (11). pp. 1697-1727. ISSN 0923-7534

Proceedings Paper

Huddart, R, Henry, A orcid.org/0000-0002-5379-6618, Staffurth, J et al. (16 more authors) (2018) OC-0058: Clinical outcomes of the first rct of adaptive radiotherapy in bladder cancer (HYBRID CRUK/12/055). In: Radiotherapy and Oncology. ESTRO 37, 20-24 Apr 2018, Barcelona, Spain. Elsevier , S25-S26.

This list was generated on Sat Aug 1 22:49:30 2020 BST.